Clinical Trials in New York State

Showing 1701-1720 of 14,718 trials

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

NCT04652570

This study is a Phase 1b/2a, open-label, sequential-cohort, dose escalation, and dose expansion study to evaluate the safety, tolerability, PK, and PD of VB119 in subjects with primary MN

Membranous Nephropathy

Tenet Medicines6 participantsStarted May 2021

Los Angeles, California, United States • Albany, New York, United States • Bethlehem, Pennsylvania, United States +1 more locations

RECRUITING69 miles

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

NCT06584357

Bio-Hermes-002 is a 120-day cross-sectional study that will result in a blood, CSF, retinal, digital, MRI, and PET brain imaging biomarker database that can be used to determine the primary objective. Digital biomarkers and blood-based biomarkers will be tested to determine whether a meaningful relationship exists between biomarkers alone or in combination with tau or amyloid brain pathology identified through PET images.

Mild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease, Early Onset+3 more

GAP Innovations, PBC1,200 participantsStarted Sep 2024

Atlantis, Florida, United States • Aventura, Florida, United States • Clermont, Florida, United States +22 more locations

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Find Trials by Condition in New York State

Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC

A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing

A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

Study of Bitopertin in Participants With EPP or XLP (APOLLO)

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

Siplizumab in T1DM

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment